Sonoma Pharmaceuticals, Inc.
SNOA
$2.76
$0.010.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -819.00K | -534.00K | -1.24M | -776.00K | -928.00K |
| Total Depreciation and Amortization | 34.00K | 36.00K | 36.00K | 31.00K | 33.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -78.00K | 143.00K | -298.00K | 452.00K | 28.00K |
| Change in Net Operating Assets | 99.00K | -280.00K | -512.00K | 198.00K | 1.43M |
| Cash from Operations | -764.00K | -635.00K | -2.02M | -95.00K | 565.00K |
| Capital Expenditure | -47.00K | -10.00K | -106.00K | -47.00K | -2.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -47.00K | -10.00K | -106.00K | -47.00K | -2.00K |
| Total Debt Issued | -- | -- | -- | 274.00K | -- |
| Total Debt Repaid | -56.00K | -83.00K | -81.00K | -81.00K | -82.00K |
| Issuance of Common Stock | 266.00K | 21.00K | 23.00K | 49.00K | 790.00K |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 210.00K | -62.00K | -58.00K | 242.00K | 708.00K |
| Foreign Exchange rate Adjustments | 127.00K | 137.00K | 410.00K | 38.00K | -113.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -474.00K | -570.00K | -1.77M | 138.00K | 1.16M |